| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Akiko Nakahama Appointed as Director since June 2025 | Director | 16-Jun-2025 | Current |
Girish Dixit Appointed as Director since October 2019 | Director | 24-Oct-2019 | Current |
Kentaro Nagane Appointed as Director since March 2024 | Director | 22-Mar-2024 | Current |
Masahito Suzuki Appointed as Director since June 2025 | Director | 16-Jun-2025 | Current |
Mitsuru Shomon Appointed as Director since September 2021 | Director | 16-Sep-2021 | Current |
Shohei Kanazawa Appointed as Director since June 2020 | Director | 25-Jun-2020 | Current |
Takuya Kijima Appointed as Additional Director since October 2025 | Additional Director | 17-Oct-2025 | Current |
Premium access Complete director detailsUnlock the complete director and KMP records available for Eisai Pharmaceuticals India Private Limited.
Verified entity values are shown only after access is granted. | |||
People Timeline
Explore the timeline of key personnel in Eisai Pharmaceuticals India Private Limited's leadership journey.
Loading...
Contact Details
- Address Plot Nos. 96, 97, 98, 124 & 126, Visakha Pharmacity Limited (Sez), Paravada Mandal, Paravada Andhra Pradesh, 531019, India
- Telephone Upgrade
- Email Upgrade
- Pin Code 531019
- Country India
- Website eisai.co.in
Frequently Asked Questions
You can contact Eisai Pharmaceuticals India Private Limited through their registered address at Plot Nos. 96, 97, 98, 124 & 126, Visakha Pharmacity Limited (Sez), Paravada Mandal, Paravada Andhra Pradesh, 531019, India, or via their website at eisai.co.in. Social media links are also provided where applicable.
The current directors of Eisai Pharmaceuticals India Private Limited are listed above in the "Current Directors & Signatories" section. You can view their names, designations, and appointment dates.
- SHOHEI KANAZAWA
- Kentaro Nagane
- GIRISH DIXIT
- MITSURU SHOMON
- Akiko Nakahama
- Masahito Suzuki
- Takuya Kijima
Past director details are available under the "Past Directors & Signatories" tab. You may need to upgrade your subscription to view detailed information.